Mechanisms for GH action on epithelial cells
Mechanisms for GH action on epithelial cells
批准号:
10578571
负责人:
SHLOMO MELMED
金额:
$36.74万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
未结题
起止时间:
2018-04-01 至 2028-03-31
关键词:
3-DimensionalAffectAgeAgingApoptosisAttenuatedCRISPR/Cas technologyCell AgingCell ProliferationCellsChromosomal InstabilityCoculture TechniquesColonDNADNA DamageDNA RepairDNA Repair PathwayDNA-PKcsDataDevicesEndocrineEpithelial CellsEpitheliumFibroblastsGene ExpressionGenesGenomicsGrowthGrowth Hormone ReceptorHomeostasisHumanIGF1 geneIn VitroIndividualIntestinesJAK2 geneKnockout MiceLeftLentivirusMalignant NeoplasmsMediatingMetabolicMetabolic dysfunctionMetforminMicrofluidic MicrochipsModelingMusMutationNeoplasmsNonhomologous DNA End JoiningOncogenesOrganoidsPathway interactionsPatientsPeripheralPhenotypePhosphoric Monoester HydrolasesPhosphorylation InhibitionPluripotent Stem CellsProliferatingPublishingRattusReceptor SignalingRegulationRoleSignal TransductionSomatotropinSomatropinSpecimenTP53 geneTelomere ShorteningTestingTissue-Specific Gene ExpressionTissuesTransgenic MiceTransgenic ModelUltraviolet Raysagedantagonistautocrinechemotherapycohortcolon growthdesignds-DNAexperimental studygenomic profileshomologous recombinationhormonal signalshormone regulationin vivoinduced pluripotent stem cellinhibitorinnovationmouse modelnoveloverexpressionparacrinepegvisomantpharmacologicreceptorrepairedresponsesenescencesingle-cell RNA sequencingstressortissue degenerationtranscriptome sequencing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Accumulated damaged DNA, if left unrepaired, may disrupt tissue homeostasis, enabling a milieu favoring
tissue degeneration, cancer, and metabolic dysfunction. DNA damage response and repair pathways are
attenuated with aging and may also result in cell senescence, with senescence-associated secretory phenotype
(SASP) promoting DNA damage and cell proliferation in neighboring cells, or in apoptosis. Non-pituitary growth
hormone (npGH), synthesized locally in peripheral tissues, is recognized by the widely expressed GH receptor
(GHR), and acts through autocrine/paracrine mechanisms. Our preliminary results show that npGH is induced
by DNA damage in aged human colon tissues, in induced pluripotent stem cell (iPSC)-derived human colon 3D
organoids, in hypophysectomized rat colon lacking endocrine GH, and in senescent colon cells. In turn, npGH
suppresses DNA repair, further reinforcing DNA damage and resulting in chromosomal instability. We propose
a novel hypothesis supporting the role of local epithelial GH as an adverse determinant of age-associated DNA
damage accumulation and as a marker of epithelial aging.
We will assess npGH induction and DNA damage in aged colon organoids, and Colon Intestine-Chip
microfluidic devices. We will examine npGH expression in human colon tissue specimens derived from age-
determined cohorts, assess spatial genomic profiles in conjunction with cells expressing npGH, and elucidate
npGH as a cause of chromosomal instability. We will explore signaling mechanisms for npGH regulation of DNA
damage response activity, senescence pathways, and DNA damage repair. Epithelial GHR signaling in vitro will
be blocked with the GHR antagonist pegvisomant, a JAK2 inhibitor, and metformin. We will assess npGH actions
in aged tissues derived from colon-specific and universal GHR knockout mice, and in GH overexpressing
transgenic mice, and also assess npGH paracrine effects on colon epithelial somatic copy number alteration
(sCNA) and respective genes affected by sCNA. We will study whether npGH is expressed in senescent cells, and
whether it affects adjacent cell DNA damage and senescence. We will test paracrine npGH effects on senescence
in Colon Intestine-Chip devices co-cultured with human colon fibroblast npGH transfectants, and will confirm
in vitro results in transgenic models overexpressing GH or in GHR knockout mice.
We largely focus on validated human colon epithelial models, yet experiments in this proposal are designed
to elucidate a universal mechanism whereby local npGH reinforces epithelial age-associated DNA damage
leading to tissue degeneration and or neoplasia.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.isci.2023.108117
发表时间:
2023-11-17
期刊:
ISCIENCE
影响因子:
5.8
作者:
[Apaydin, Tugce, Zonis, Svetlana, Zhou, Cuiqi, Valencia, Christian Wong, Barrett, Robert, Strous, Ger J., Mol, Jan A., Chesnokova, Vera, Melmed, Shlomo]
通讯作者:
Melmed, Shlomo
DOI:
10.1210/clinem/dgac307
发表时间:
2022-09-28
期刊:
The Journal of clinical endocrinology and metabolism
影响因子:
--
作者:
[]
通讯作者:
Generation of isogenic and homozygous MEN1 mutant cell lines from patient-derived iPSCs using CRISPR/Cas9.
使用 CRISPR/Cas9 从患者来源的 iPSC 中生成等基因和纯合的 MEN1 突变细胞系。
DOI:
10.1016/j.scr.2023.103124
发表时间:
2023
期刊:
Stem cell research
影响因子:
1.2
作者:
[Even-Zohar,Naomi, Metin-Armagan,Derya, Ben-Shlomo,Anat, Sareen,Dhruv, Melmed,Shlomo]
通讯作者:
Melmed,Shlomo
DOI:
10.1172/jci.insight.125762
发表时间:
2019-02-07
期刊:
JCI INSIGHT
影响因子:
8
作者:
[Chesnokova, Vera, Zonis, Svetlana, Melmed, Shlomo]
通讯作者:
Melmed, Shlomo
DOI:
10.1210/jendso/bvab177
发表时间:
2022-01-01
期刊:
Journal of the Endocrine Society
影响因子:
4.1
作者:
[Chesnokova V, Melmed S]
通讯作者:
Melmed S
共 7 条
Ph 2 Multicenter study of seliciclib for Cushing Disease IND 120,848 (10/10/2017)
-
批准号:10003845
-
项目类别:
-
资助金额:$46.78万
-
财政年份:2018
-
负责人:SHLOMO MELMED
-
依托单位:
Mechanisms for GH action on epithelial cells
-
批准号:9893867
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2018
-
负责人:SHLOMO MELMED
-
依托单位:
Treatment of pituitary Cushing disease with a selective CDK inhibitor, R-roscovit
-
批准号:8773516
-
项目类别:
-
资助金额:$23.44万
-
财政年份:2014
-
负责人:SHLOMO MELMED
-
依托单位:
Cedars-Sinai Biobank and Translational Research Core Facility (CS-BRCF)
-
批准号:7935157
-
项目类别:
-
资助金额:$955.29万
-
财政年份:2010
-
负责人:SHLOMO MELMED
-
依托单位:
PITUITARY TUMOR SURVEILLANCE: PATHOGENETIC CORRELATION
-
批准号:7606126
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2007
-
负责人:SHLOMO MELMED
-
依托单位:
MECHANISMS FOR PITUITARY TUMORIGENESIS
-
批准号:7606124
-
项目类别:
-
资助金额:$0.09万
-
财政年份:2007
-
负责人:SHLOMO MELMED
-
依托单位:
MECHANISMS FOR PITUITARY TUMORIGENESIS
-
批准号:7376014
-
项目类别:
-
资助金额:$0.22万
-
财政年份:2005
-
负责人:SHLOMO MELMED
-
依托单位:
PITUITARY TUMOR SURVEILLANCE: PATHOGENETIC CORRELATION
-
批准号:7376016
-
项目类别:
-
资助金额:$0.22万
-
财政年份:2005
-
负责人:SHLOMO MELMED
-
依托单位:
PITUITARY TUMOR SURVEILLANCE: PATHOGENETIC CORRELATION
-
批准号:7206322
-
项目类别:
-
资助金额:$0.18万
-
财政年份:2004
-
负责人:SHLOMO MELMED
-
依托单位:
MECHANISMS FOR PITUITARY TUMORIGENESIS
-
批准号:7206320
-
项目类别:
-
资助金额:$0.18万
-
财政年份:2004
-
负责人:SHLOMO MELMED
-
依托单位:
Metabolic consequences of securin disruption
-
批准号:7008190
-
项目类别:
-
资助金额:$31.6万
-
财政年份:2003
-
负责人:SHLOMO MELMED
-
依托单位:
Metabolic consequences of securin disruption
-
批准号:6599784
-
项目类别:
-
资助金额:$32.36万
-
财政年份:2003
-
负责人:SHLOMO MELMED
-
依托单位:
Metabolic consequences of securin disruption
-
批准号:7172931
-
项目类别:
-
资助金额:$30.68万
-
财政年份:2003
-
负责人:SHLOMO MELMED
-
依托单位:
Metabolic consequences of securin disruption
-
批准号:6833420
-
项目类别:
-
资助金额:$32.36万
-
财政年份:2003
-
负责人:SHLOMO MELMED
-
依托单位:
Pituitary Tumor Surveillance: Pathogenetic Correlation
-
批准号:7042064
-
项目类别:
-
资助金额:$1.41万
-
财政年份:2003
-
负责人:SHLOMO MELMED
-
依托单位:
Metabolic consequences of securin disruption
-
批准号:6710585
-
项目类别:
-
资助金额:$32.36万
-
财政年份:2003
-
负责人:SHLOMO MELMED
-
依托单位:
Mechanisms for Pituitary Tumorigenesis
-
批准号:7042061
-
项目类别:
-
资助金额:$1.41万
-
财政年份:2003
-
负责人:SHLOMO MELMED
-
依托单位:
Information Technology for Human Subjects Protection
-
批准号:6591413
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2002
-
负责人:SHLOMO MELMED
-
依托单位:
Gordon Research Conference on Prolactin
-
批准号:6623298
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2002
-
负责人:SHLOMO MELMED
-
依托单位:
Gordon Research Conference on Prolactin
-
批准号:6831175
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2002
-
负责人:SHLOMO MELMED
-
依托单位:
海外基金